<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00985205</url>
  </required_header>
  <id_info>
    <org_study_id>RE-ENERGIZE</org_study_id>
    <secondary_id>CIHR # 190808</secondary_id>
    <nct_id>NCT00985205</nct_id>
  </id_info>
  <brief_title>The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury</brief_title>
  <acronym>RE-ENERGIZE</acronym>
  <official_title>Effects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daren K. Heyland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Evaluation Research Unit at Kingston General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the following hypotheses:&#xD;
&#xD;
        1. Enteral glutamine administration decreases in-hospital mortality in adult patients with&#xD;
           severe thermal burn injuries.&#xD;
&#xD;
        2. Enteral glutamine administration decreases hospital-acquired blood stream infections&#xD;
           from Gram negative organisms and length of stay in ICU and hospital for adult patients&#xD;
           with severe thermal burn injuries.&#xD;
&#xD;
        3. Enteral glutamine administration will improve the physical function of surviving burn&#xD;
           injured patients and reduce their cost of care.&#xD;
&#xD;
      The objectives of this trial are to determine the overall treatment effect and safety of&#xD;
      glutamine in burn patients. Specifically, the investigators want to assess the following&#xD;
      outcomes in a sample of 1200 patients in 80 sites:&#xD;
&#xD;
        1. In patients with severe, life-threatening burn injury, what is the effect of enteral&#xD;
           glutamine on time to discharge alive from hospital&#xD;
&#xD;
        2. In patients with severe, life-threatening burn injury, what is the effect of enteral&#xD;
           glutamine on 6 month mortality, hospital-acquired blood stream infections from Gram&#xD;
           negative organisms, hospital mortality, duration of stay in ICU and hospital,&#xD;
           health-related quality of life, and health care resources?&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Burn injuries represent a public health problem worldwide, ranked fourth in all injuries and&#xD;
      are among the leading cause of disability adjusted life years in low and middle-income&#xD;
      countries. More than in any other injury, the inflammation and catabolism associated with&#xD;
      severe burns can exacerbate nutrient deficiencies, thereby predisposing patients to impaired&#xD;
      immune function and increased risk of developing infectious complications, organ dysfunction,&#xD;
      and death. Consequently, over the last few decades numerous trials have evaluated the impact&#xD;
      of different nutrition/nutrient strategies in severe burns patients. Glutamine is of&#xD;
      particular interest in this regard as it appears vital for a number of key stress-response&#xD;
      pathways in serious illness. The existing randomized trials of glutamine supplementation in&#xD;
      burns patients have suggested a significant reduction in mortality, infection, and hospital&#xD;
      length of stay. However, in other critically ill patient populations, there is a signal of&#xD;
      increased mortality associated with glutamine administration. Given this conflicting&#xD;
      evidence, burn practitioners are either harming or saving lives with glutamine use. We&#xD;
      hypothesize that the inexpensive therapeutic strategy tested in this multicenter randomized&#xD;
      controlled clinical trial of supplemental enteral glutamine in 1200 severe burn injury&#xD;
      patients will lead to lower morbidity and mortality and reduced health care costs in an&#xD;
      otherwise very devastating and disabling injury worldwide.&#xD;
&#xD;
      In our pilot study (Critical Care Medicine, 2003, 31:2444) we found a protective effect of&#xD;
      glutamine against blood infection in severely burned adult patients. In addition, a&#xD;
      significant decrease in mortality was observed with glutamine. These results should be tested&#xD;
      with a multi-center trial because our study was small and did not have mortality as an end&#xD;
      point.&#xD;
&#xD;
      The specific aims of the study are to determine the overall treatment effect and safety of&#xD;
      glutamine in burn patients. Clinical outcomes will be: mortality, time to discharge alive,&#xD;
      incidence of acquired bacteremia due to Gram negative organisms, hospital mortality, duration&#xD;
      of mechanical ventilation, ICU stay and hospital stay. The cost-effectiveness of glutamine&#xD;
      administration will also be measured if the results show a decrease in length of care or a&#xD;
      reduced incidence of acquired bacteremia due to Gram negative organisms with glutamine.&#xD;
&#xD;
      The study will be a large, multicenter, double-blind, pragmatic, randomized controlled trial&#xD;
      of 1200 patients with severe burns randomly allocated to receive enteral glutamine or&#xD;
      placebo. Randomization will be concealed and stratified by site allocating patients 1:1 to&#xD;
      either glutamine or matching placebo by the method of permuted blocks of random undisclosed&#xD;
      size within strata. Patients will be adults, a minimum of 18 years old, with deep 2nd and/or&#xD;
      3rd degree burns requiring grafting, and for patients age 18 - 39 years a (Total Body Surface&#xD;
      Area) TBSA burn ≥ 20% or in the presence of an inhalation injury a minimum of 15% TBSA burn&#xD;
      is required; for patients age 40 - 59 years a TBSA burn ≥ 15% is required; for patients aged&#xD;
      60 years or older a TBSA burn ≥ 10% is required. The study will include approximately 80 burn&#xD;
      centers in Canada, the US, Europe and Latin America. Patients will receive glutamine or a&#xD;
      placebo through their feeding tube, every 4 hours or TID or QID if taking things by mouth,&#xD;
      for a total of 0.5 g/kg/day for patients with a BMI &lt;35. Patients with a BMI ≥35 will receive&#xD;
      0.5 g/kg/day based on an obesity-adjusted body weight. The study intervention will be&#xD;
      administered until ≥7 days after the last successful grafting operation or until discharge&#xD;
      from acute care unit or 3 months from admission, whichever comes first. Resuscitation,&#xD;
      nutritional support, pain management, infection control and surgical care will be done&#xD;
      according to standardized procedures.&#xD;
&#xD;
      The Data will be collected and managed by a professional and centralized organization for&#xD;
      multi centres clinical research (Clinical Evaluation Research Unit, Kingston, Ontario,&#xD;
      Canada).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2010</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Discharge Alive</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>6 Month Mortality</measure>
    <time_frame>6 Months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Health-Related Quality of Life - in particular the physical function domain of the SF-36, ADL, and IADL questionnaires.</measure>
    <time_frame>6 Month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of acquired bacteremia due to Gram negative organisms</measure>
    <time_frame>3 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Hospital Mortality</measure>
    <time_frame>3 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Duration of Mechanical Ventilation</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>ICU Stay</measure>
    <time_frame>3 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Hospital Stay</measure>
    <time_frame>3 Months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1201</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Enteral Glutamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5 g/kg/day mixed in water and given via nasogastric or feeding tube as boluses q 4 hrs or TID or QID if po</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Mixed in with water and given via nasogastric or feeding tube as boluses q 4hrs or TID or QID if po</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enteral Glutamine</intervention_name>
    <description>0.5g/kg/day powdered glutamine to be mixed in with water and given via nasogastric or feeding tube q4 hrs or TID or QID if po.</description>
    <arm_group_label>Enteral Glutamine</arm_group_label>
    <other_name>Glutamine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Maltodextrin mixed with water given via NG or feeding tube Q 4 hours or TID or QID if po.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Maltodextrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Deep 2nd and/or 3rd degree burns requiring grafting&#xD;
&#xD;
          2. Patient meets one of the following 4 criteria:&#xD;
&#xD;
               1. Patients 18 - 39 years of age with ≥ 20% TBSA* burn&#xD;
&#xD;
               2. Patients 18 - 39 years of age with ≥ 15% TBSA* burn and with inhalation injury&#xD;
&#xD;
               3. Patients 40 - 59 years of age with ≥ 15% TBSA* burn&#xD;
&#xD;
               4. Patients ≥ 60 years of age ≥ 10% TBSA* *TBSA - Total Body Surface Area&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. &gt; 72 hrs from admission to ICU to time of consent.&#xD;
&#xD;
          2. Patients younger than 18 years of age.&#xD;
&#xD;
          3. a) Patients without known renal disease and renal dysfunction defined as a serum&#xD;
             creatinine &gt;171 µmol/L or a urine output of less than 500 mL/last 24 hours (or 80&#xD;
             mL/last 4 hours if a 24 hour period of observation is not available).&#xD;
&#xD;
             b) Patients with acute on chronic renal failure (pre-dialysis) with an absolute&#xD;
             increase of &gt;80 µmol/L from baseline or pre-admission creatinine or a urine output of&#xD;
             &lt;500 mL/last 24 hours (or 80 mL/last 4 hours).&#xD;
&#xD;
             c) Patients with chronic renal failure on dialysis will be excluded.&#xD;
&#xD;
          4. Liver cirrhosis - Child-Pugh class C liver disease&#xD;
&#xD;
          5. Pregnant or lactating females.&#xD;
&#xD;
          6. Contra-indication for EN: intestinal occlusion or perforation, intra-abdominal injury.&#xD;
&#xD;
          7. Patients with injuries from high voltage electrical contact.&#xD;
&#xD;
          8. Patients who are moribund (not expected to survive the next 72 hours).&#xD;
&#xD;
          9. Patients with extreme body sizes: BMI &lt; 18 or &gt; 50&#xD;
&#xD;
         10. Enrollment in another industry sponsored ICU intervention study.&#xD;
&#xD;
         11. Received glutamine supplement for &gt; 24 hrs prior to randomization&#xD;
&#xD;
         12. Known allergy to maltodextrin, corn starch, corn, corn products or glutamine.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daren Heyland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of South Alabama Medical Center</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Burn Center at Maricopa Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern California Regional Burn Ctr at LAC &amp; USC Med. Ctr.</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90089-9235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shriners Hospitals for Children Northern California</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology, University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Colorado Medical Center - Banner Health</name>
      <address>
        <city>Greeley</city>
        <state>Colorado</state>
        <zip>80631</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Connecticut Burn Center</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Burn Center at Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20782</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shands Burn Center at the University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of South Florida/Tampa Gen. Hosp. Reg. Burn Center, FL</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joseph M Still Burn Center</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30909</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Surgery University of Iowa Hospitals &amp; Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHI St.Elizabeth Regional Burn Center</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68150</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198-7835</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Akron's Children's Hospital, Paul &amp; Carol David Foundation</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308-1062</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexnar Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Emmanuel Hospital &amp; Health Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Western Pennsylvania Hospital Burn Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Firefighters' Regional Burn Center TN, University of Tennesse Health &amp; Sciences Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>8563</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JBSA Fort Sam Houston</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234-7767</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann/UTHSC</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harbourview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195-9796</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia-St. Mary's, Milwaukee, Wi</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HHS/Hamilton Firefighters Burn Unit</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUM/Centre des Grands Brules</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 0A9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HEJ/Centre des Grands Brules</name>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Tecnologico de Santo Domingo</name>
      <address>
        <city>Santo Domingo</city>
        <zip>10602</zip>
        <country>Dominican Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RWTH Aachen University</name>
      <address>
        <city>Aachen</city>
        <state>North Rhine-Westphalia</state>
        <zip>52062</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berufsgenossenschaftliche Unfallklinik Ludwigshafen</name>
      <address>
        <city>Ludwigshafen</city>
        <state>Rhein</state>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O.U. Citta della Salute e della Scienza di Torino</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Nacional de Quemaduras y Cirugia Reconstructiva</name>
      <address>
        <city>Asunción</city>
        <country>Paraguay</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>75124</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Siriraj Hospital, Divison of Trauma Surgery, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <state>NOI</state>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Chulalongkorn Memorial Hospital Chulalongkorn University</name>
      <address>
        <city>Bangkok</city>
        <state>Pathumwan</state>
        <zip>1873</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Khon Kaen University</name>
      <address>
        <city>Mueang Nonthaburi</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <state>Edgbaston</state>
        <zip>B15 2GW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Helens &amp; Knowsley Teaching Hospitals</name>
      <address>
        <city>Liverpool</city>
        <state>England</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chelsea and Westminster Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>SW10 9NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newcastle upon Tyne Hospitals</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <state>England</state>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manchester University NHSFT</name>
      <address>
        <city>Manchester</city>
        <state>London</state>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinderfields Hospital, Mid Yorkshire NHS Trust</name>
      <address>
        <city>London</city>
        <state>West Yorkshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Dominican Republic</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Paraguay</country>
    <country>Singapore</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Thailand</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Australia</country>
    <country>Mexico</country>
  </removed_countries>
  <link>
    <url>http://www.criticalcarenutrition.com</url>
    <description>Related Info</description>
  </link>
  <reference>
    <citation>Garrel D, Patenaude J, Nedelec B, Samson L, Dorais J, Champoux J, D'Elia M, Bernier J. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med. 2003 Oct;31(10):2444-9.</citation>
    <PMID>14530749</PMID>
  </reference>
  <reference>
    <citation>Zhou YP, Jiang ZM, Sun YH, Wang XR, Ma EL, Wilmore D. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr. 2003 Jul-Aug;27(4):241-5.</citation>
    <PMID>12903886</PMID>
  </reference>
  <reference>
    <citation>Peng X, Yan H, You Z, Wang P, Wang S. Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns. 2004 Mar;30(2):135-9.</citation>
    <PMID>15019120</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 25, 2009</study_first_submitted>
  <study_first_submitted_qc>September 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2009</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Evaluation Research Unit at Kingston General Hospital</investigator_affiliation>
    <investigator_full_name>Daren K. Heyland</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Randomized Clinical Trial</keyword>
  <keyword>Glutamine</keyword>
  <keyword>Themal Burn Injuries</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Outcome Assessment</keyword>
  <keyword>Critical Care</keyword>
  <keyword>Total Body Surface Area</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

